Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids

Vaccine

Volumn 18, Issue 3-4, 1999, Pages 251-258

  Heal, Karen G ^a   Hill, H Rachael ^a   Stockley, Peter G ^a   Hollingdale, Michael R ^a   Taylor Robinson, Andrew W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Malaria; MS2 bacteriophage coat protein; Peptide delivery

Indexed keywords

CHIMERIC PROTEIN; CYTOKINE; EPITOPE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MALARIA VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; CHIMERA; CONFERENCE PAPER; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; MS2 VIRUS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIGENS, PROTOZOAN; CAPSID; EPITOPES; LEVIVIRUS; LIVER; MALARIA, FALCIPARUM; MICE; MICE, INBRED BALB C; PEPTIDES; RNA, VIRAL;

EID: 0032876566     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00209-1     Document Type: Conference Paper

References (25)

1. Porter R., Whelan J. Synthetic peptides as antigens. CIBA Foundation Symposium 119. 1986;Wiley, Chichester.
2. Clarke B.E., Newton S.E., Carroll A.R., et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature. 330:1987;381-384.
3. Dedieu J.F., Ronco J., Van der Werf S., Hogle J M., Henin Y., Girard M. Poliovirus chimeras expressing sequences from the principal neutralizing domain of human immunodeficiency virus type 1. J. Virol. 66:1992;3161-3167.
4. Mastico R.A., Talbot S.J., Stockley P.G. Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid. J. Gen. Virol. 74:1993;541-548.
5. Valegård K., Murray J.B., Stockley P.G., Stonehouse N.J., Lilljas L. Crystal structure of an RNA bacteriophage coat protein-operator complex. Nature. 371:1994;623-626.
6. Scheller L.F., Azad A.F. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sprozoites. Proc. Natl. Acad. Sci. USA. 92:1995;4066-4068.
7. Hoffman S.L., Franke E.D., Hollingdale M.R., Druilhe P. Attacking the infected hepatocyte. Hoffman S.L. Malaria vaccine development. A multi-immune response approach. 1996;35-75 ASM Press, Washington, DC.
8. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
9. Sidney J., Grey H.M., Southwood S., et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45:1996;79-93.
10. Falk K., Rötzschke O., Stevanovic' S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290-296.
11. Connelly M., King C.L., Bucci K., et al. T cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect. Immun. 65:1997;5082-5087.
12. Maruyama T., Gojobori T., Aota S., Ikemura T. Codon usage tabulated from the Genbank genetic sequence data. Nucl. Acids Res. 14:1986;r151-r197.
13. Shägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range for 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
14. + T cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology. 77:1992;99-105.
15. + T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Eur. J. Immunol. 24:1994;158-164.
16. Taylor-Robinson A.W., Phillips R.S., Severn A., Moncada S., Liew F.Y. The role of Th1 and Th2 cells in a rodent malaria infection. Science. 260:1993;1931-1934.
17. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:1989;2081-2095.
18. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 146:1991;3444-3451.
19. Hill A.V.S., Allsopp C.E., Kwiatkowski D., et al. Common west African HLA antigens are associated with protection from severe malaria. Nature. 352:1991;595-600.
20. Hill A.V.S., Elvin J., Willis A.C., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434-439.
21. Smith T., Bhatia K., Prasad M., Koki G., Alpers M. Altitude, language, and class I HLA allele frequencies in Papua New Guinea. Am. J. Phys. Anthropol. 95:1994;155-168.
22. Perlaza B.L., Arevalo-Herrera M., Brahimi K., et al. Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys. Infect. Immun. 66:1998;3423-3428.
23. + T cells and antibodies required for immunity to malaria sporozoites. Nature. 330:1987;664-666.
24. Druilhe P., Puebla R M., Miltgen F., Perrin L., Gentilini M. Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33:1984;336-341.
25. Kastelein R.A., Berkhout B., Overbeck G.P., Van Duin J. Effects of the sequences upstream from the ribosome-binding site on the yield of protein from the cloned gene for phage MS2 coat protein. Gene. 23:1983;245-254.